Skip to main content

Find Clinical Trials

Clinical trial condition

PAH

Explore clinical trials studying PAH. Study availability and eligibility vary by location and protocol.

10 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

PAH trial results

Not yet recruiting

Impact of an Optimized Omega-3 Formulation on Inflammation and Endothelial Dysfunction in Pulmonary Arterial Hypertension

NCT07697235

Conditions: Hypertension, Pulmonary, Inflammation, Lung Diseases, +5 more
Locations: Not specified

View Trial Details

Not yet recruiting

Sota-ES - Sotatercept in Patients With Congenital Heart Disease and Eisenmenger´s Syndrome

NCT07498803

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +7 more
Locations: Not specified

View Trial Details

Not yet recruiting

Effects of Pulmonary Rehabilitation on Quality of Life and Health in Pulmonary Arterial Hypertension Patients

NCT06973382

Conditions: CTEPH, PAH
Locations: Not specified

View Trial Details

Enrolling by invitation

TSPO Endothelial - EMPATHY

NCT07697183

Conditions: PAH
Locations: NIHR Imperial CRF London, United Kingdom

View Trial Details

Enrolling by invitation

A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension

NCT03683186

Conditions: Cardiovascular Diseases, Connective Tissue Diseases, Familial Primary Pulmonary Hypertension, +10 more
Locations: St. Joseph's Hospital and Medical Center-Norton Thoracic Institute Phoenix, Arizona, United States

University of Arizona Tucson, Arizona, United States

UCSD Health Sciences La Jolla, California, United States

Ronald Reagan UCLA Medical Center Los Angeles, California, United States

View all 190 locations

View Trial Details

Completed

A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

NCT03626688

Conditions: Cardiovascular Diseases, Connective Tissue Diseases, Familial Primary Pulmonary Hypertension, +10 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States

University of Arizona Tucson, Arizona, United States

UCSD Health Sciences La Jolla, California, United States

View all 209 locations

View Trial Details

Completed

Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years

NCT02276872

Conditions: PAH
Locations: Lucile Packard Children's Hospital Palo Alto, California, United States

University of California San Francisco San Francisco, California, United States

Children's Hospital Colorado Aurora, Colorado, United States

Boston Children's Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Bioequivalence Study of Macitentan and Tadalafil Film-coated Tablets 10 Mg/40 Mg and 'PrOpsynvi®' Macitentan and Tadalafil Film-coated Tablets 10 Mg/40 Mg

NCT06553937

Conditions: PAH
Locations: Cliantha Research Limited Ahmedabad, Gujarat, India

View Trial Details

Completed

Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg and 'PrOpsynvi®' Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg

NCT06553924

Conditions: PAH
Locations: Cliantha Research Limited Ahmedabad, Gujarat, India

View Trial Details

Completed

Pulmonary Hypertension and Imatinib

NCT01092897

Conditions: PAH
Locations: University of Colorado Denver Aurora, Colorado, United States

Cleveland Clinic Florida Weston, Florida, United States

Johns Hopkins Baltimore, Maryland, United States

Tufts Medical Center Boston, Massachusetts, United States

View Trial Details